test

George Song

@Superstring Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$114.248MTotal holdings27
Assets growth rate44.02%Assets growth rate (2-Q avg)-1.76%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Superstring Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 27 positions.

Assets under management

The assets under management (AUM) of Superstring Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 114.248M in assets, with a quarterly growth rate of 44.02% and a 2-quarter average growth rate of -1.76%. The portfolio is managed by George Song, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ZLABZai Lab Ltd
Recent Activity
Increased 237.83%
15.36%
$17.548M↑ Call
726,932 shares@ $24.14 avg price
CYTKCytokinetics Inc
Recent Activity
Increased 15.02%
9.98%
$11.394M
215,798 shares@ $52.8 avg price
TERNTerns Pharmaceuticals Inc
Recent Activity
Increased 40.99%
9.85%
$11.247M
1.349M shares@ $8.35 avg price
GPCRStructure Therapeutics Inc
Recent Activity
New Position
8.73%
$9.965M
227,047 shares@ $43.9 avg price
ORICOric Pharmaceuticals Inc
Recent Activity
New Position
8.52%
$9.733M
949,522 shares@ $10.26 avg price
TILInstil Bio Inc
Recent Activity
New Position
6.34%
$7.24M
107,545 shares@ $67.32 avg price
NVCRNovocure Ltd
Recent Activity
Increased 487.09%
5.38%
$6.138M
392,711 shares@ $15.64 avg price
BBIOBridgebio Pharma Inc
Recent Activity
Increased 3.12%
5.06%
$5.771M
226,684 shares@ $25.47 avg price
FATEFate Therapeutics Inc
Recent Activity
Increased 194.95%
4.5%
$5.134M
1.467M shares@ $3.5 avg price
CAPRCapricor Therapeutics Inc
Recent Activity
New Position
4.5%
$5.131M
337,347 shares@ $15.22 avg price